Clinical trial
Early Administration of Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial
NCT04632121 is registered in ClinicalTrials.gov with Ahmed Abdel Nasser Abdel Rady as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Administration of Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial
- Lead sponsor
- Ahmed Abdel Nasser Abdel Rady
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2021
- Completion date
- December 29, 2023
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
nicorandil